Why choose us

  • Expertise BioVirtus can execute large long-confinement studies with up to 45 subjects.
  • Effectiveness Thanks to a large database of subjects BioVirtus guarantees swift and effective recruitment, screening and enrolment.
  • Easiness We have the ability to quickly enrol patients with various diseases.     

Our Services 

BioVirtus Research Site provides a wide range of services in early clinical research to companies in the generic, biotechnology and pharmaceutical industry.

Thanks to our excellent knowledge of the local IRB/IEC, regulatory and sponsors’ requirements we can offer comprehensive planning and conduct of studies at our dedicated research facility.

Studies are performed by trained and experienced study team, in full compliance with European and international requirements, with the highest ethical standards and ICH Good Clinical Practice, and with regard to maximum attention of the subjects’ safety.

We are qualified to perform even the most complex research projects. We specialize in the following studies:

  • First-in-Man
  • Phase I (healthy volunteers, renal and hepatic impaired patients)
  • Phase I-IIa in patients with related disease
  • Proof-of-Concept
  • Bioequivalence
  • Bioavailability and drug metabolism
  • Biosimilars
  • Therapeutic equivalence
  • PK/PD studies.

For each single project BioVirtus offers the following services:

  • Start-up Activities
  • Study Subjects’ Recruitment
  • Medical procedures
  • Laboratory procedures
  • Pharmacy procedures
  • Project Management
  • Consulting
  • Quality Assurance & Control.